X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-05-21 | PHVS | Monges Viviane | Dir | S - Sale | $30.29 | -9,667 | 5,500 | -64% | -$292,853 | ||||||
| DM | 2026-05-21 | PHVS | Nijdam Anna | Principal Accounting Officer | S - Sale+OE | $30.70 | -7,330 | 48,945 | -13% | -$225,055 | |||||
2026-05-21 | PHVS | Nassif David W. | CFO , CLO | S - Sale | $30.31 | -10,000 | 120,300 | -8% | -$303,076 | ||||||
| D | 2026-05-20 | PHVS | Bjork Elisabeth | Dir | S - Sale+OE | $29.32 | -10,000 | 15,167 | -40% | -$293,166 | |||||
2026-05-18 | PHVS | Modig Berndt | CEO | S - Sale | $29.22 | -2,292 | 137,500 | -2% | -$66,977 | ||||||
| D | 2026-05-15 | PHVS | Glassman Robert | Dir | S - Sale+OE | $29.82 | -10,000 | 10,500 | -49% | -$298,245 | |||||
2026-05-15 | PHVS | Abele Stefan Andreas | Chief Technical Ops Officer | S - Sale | $29.82 | -8,748 | 35,194 | -20% | -$260,864 | ||||||
2026-05-15 | PHVS | Souverijns Wim | Chief Commercial Officer | S - Sale | $29.92 | -10,000 | 45,111 | -18% | -$299,163 | ||||||
| D | 2026-05-01 | PHVS | Lu Peng | Chief Medical Officer | S - Sale+OE | $30.17 | -14,166 | 66,083 | -18% | -$427,419 | |||||
| M | 2026-04-29 | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale | $30.29 | -32,900 | 355,167 | -8% | -$996,545 | |||||
| DM | 2026-04-29 | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $30.23 | -48,300 | 190,419 | -20% | -$1,459,970 | |||||
| DM | 2026-04-29 | PHVS | Lu Peng | Chief Medical Officer | S - Sale+OE | $30.21 | -18,733 | 66,083 | -22% | -$565,859 | |||||
| M | 2026-04-22 | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale | $30.05 | -7,100 | 388,067 | -2% | -$213,382 | |||||
| DM | 2026-04-22 | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $30.05 | -14,700 | 213,319 | -6% | -$441,726 | |||||
| DM | 2026-04-22 | PHVS | Lu Peng | Chief Medical Officer | S - Sale+OE | $30.05 | -7,101 | 66,083 | -10% | -$213,405 | |||||
2026-04-16 | PHVS | Modig Berndt | CEO | S - Sale | $28.60 | -2,292 | 1,089,792 | 0% | -$65,559 | ||||||
2026-04-09 | PHVS | Modig Berndt | CEO | S - Sale | $27.74 | -23,333 | 1,092,084 | -2% | -$647,281 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |